Das ist der Job
This position reports directly to the Area Business Lead.
Darum lohnt es sich
As a new member of the Revolution Medicines team, you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway. Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers.
The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins.
The company’s RAS(ON) inhibitors daraxonrasib (RMC‑6236), a RAS(ON) multi‑selective inhibitor; elironrasib (RMC‑6291), a RAS(ON) G12C‑selective inhibitor; zoldonrasib (RMC‑9805), a RAS(ON) G12D‑selective inhibitor; and RMC‑5127, a RAS(ON) G12V‑selective inhibitor, are currently in clinical development.
Opportunity
The Senior Oncology Account Manager is responsible for the direct promotion of Revolution Medicines’ products and for building strong professional relationships with key customers and stakeholders, including private practices, medical group practices, hospitals/academic medical centers, and office ancillary staff involved in the care of cancer patients.
The Senior Oncology Account Manager will act as both a clinical and business leader who exemplifies the values of Revolution Medicines by providing approved disease and product information, as well as resources, to key decision‑makers and stakeholders within their assigned territory.
